Edwards Lifesciences has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
Edwards Lifesciences: Q3 Earnings Snapshot
Edwards Lifesciences will release its third-quarter earnings this month, and analysts anticipate a double-digit bottom-line growth.
The S&P 500 Index ($SPX ) (SPY ) today is up by +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.11%. Stocks today are slightly...
September S&P 500 E-Mini futures (ESU24) are up +0.10%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.09% this morning as caution prevailed ahead of the Federal Reserve’s interest rate decision,...
While Edwards Lifesciences has underperformed the broader medical devices industry recently, analysts are moderately bullish on the stock's prospects.
Becton, Dickinson, and Company BDX, popularly known as BD, completed its acquisition of Edwards Lifesciences Corporation EW Critical Care product group, renaming it BD Advanced Patient Monitoring.BD had...
This MedTech leader is back on track with profitable growth.
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.89%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.68%. US stocks...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.09%. US stocks today gave up an...